Tyra Biosciences, Inc. (TYRA)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS90240B1061
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Tyra Biosciences, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:13. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 02 Mar 2027 08:00 | -0.73 | — | — | Upcoming |
| 10 Nov 2026 08:00 | -0.66 | -0.74 | -11.3% | Miss |
| 04 Aug 2026 16:00 | -0.64 | -0.69 | -7.0% | Miss |
| 13 May 2026 08:00 | -0.59 | -0.64 | -8.6% | Miss |
| 02 Mar 2026 16:00 | -0.53 | -0.57 | -8.5% | Miss |
| 05 Nov 2025 16:00 | -0.51 | -0.50 | +2.0% | Beat |
| 14 Aug 2025 16:00 | -0.51 | -0.47 | +7.7% | Beat |
| 08 May 2025 16:00 | -0.48 | -0.47 | +1.3% | Beat |
| 27 Mar 2025 16:00 | -0.47 | -0.43 | +7.9% | Beat |
| 07 Nov 2024 16:00 | -0.39 | -0.41 | -4.6% | Miss |
| 07 Aug 2024 16:00 | -0.39 | -0.32 | +18.4% | Beat |
| 09 May 2024 16:00 | -0.46 | -0.35 | +23.4% | Beat |
| 19 Mar 2024 16:00 | -0.47 | -0.53 | -12.4% | Miss |
| 07 Nov 2023 16:00 | -0.35 | -0.49 | -41.6% | Miss |
| 10 Aug 2023 16:00 | -0.34 | -0.31 | +7.7% | Beat |
| 04 May 2023 16:00 | -0.37 | -0.28 | +24.3% | Beat |
| 22 Mar 2023 16:00 | -0.35 | -0.31 | +11.4% | Beat |
| 03 Nov 2022 16:00 | -0.39 | -0.30 | +23.7% | Beat |
| 04 Aug 2022 16:00 | -0.30 | -0.36 | -20.0% | Miss |
| 05 May 2022 16:00 | -0.20 | -0.36 | -80.0% | Miss |
| 03 Mar 2022 16:00 | -0.21 | -0.24 | -11.6% | Miss |
| 03 Nov 2021 16:00 | -0.60 | -0.72 | -20.0% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | — | -119.9M | — | -2.01 | -33.1% | -95.3M |
| 2024 | 0 | — | -86.5M | — | -1.51 | +6.8% | -70.4M |
| 2023 | 0 | — | -69.1M | — | -1.62 | -22.7% | -50.9M |
| 2022 | 0 | — | -55.3M | — | -1.32 | — | -50.8M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 21.08 | 23.00 | 19.27 | 19.27 | -8.54% | 5,621,708 | |
| Oct 2026 | 21.78 | 22.37 | 18.25 | 21.07 | -3.66% | 14,168,400 | |
| Sep 2026 | 24.99 | 29.56 | 18.66 | 21.87 | -12.62% | 29,819,500 | |
| Aug 2026 | 31.06 | 32.99 | 24.17 | 25.03 | -21.49% | 11,719,100 | |
| Jul 2026 | 31.92 | 33.72 | 29.26 | 31.88 | -0.19% | 12,803,200 | |
| Jun 2026 | 33.35 | 33.35 | 24.66 | 31.94 | -4.40% | 24,778,500 | |
| May 2026 | 34.77 | 37.27 | 32.16 | 33.41 | -3.86% | 13,559,700 | |
| Apr 2026 | 39.10 | 40.65 | 33.30 | 34.75 | -9.27% | 23,214,700 | |
| Mar 2026 | 32.02 | 39.15 | 30.10 | 38.30 | +14.98% | 29,429,500 | |
| Feb 2026 | 30.65 | 35.71 | 24.88 | 33.31 | +8.08% | 15,230,500 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- How Phase 2 Cancer Trial Data At Tyra Biosciences (TYRA) Has Changed Its Investment Story (opens in a new tab) Simply Wall St. · 12 Nov 2026 00:23
- Wedbush Maintains Outperform on Tyra Biosciences, Raises Price Target to $57 (opens in a new tab) Benzinga · 11 Nov 2026 10:08
- HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $27 (opens in a new tab) Benzinga · 11 Nov 2026 08:06
- Tyra Biosciences Reports Third Quarter 2026 Financial Results and Recent Highlights (opens in a new tab) 10 Nov 2026 13:00
- Tyra Biosciences Q3 EPS $(0.74) Misses $(0.69) Estimate (opens in a new tab) Benzinga · 10 Nov 2026 09:10
- Tyra Biosciences to Participate in Upcoming Investor Conferences (opens in a new tab) 05 Nov 2026 21:05
- Tyra Biosciences (TYRA) Stock Looks Rich Against Its Book Value (opens in a new tab) Simply Wall St. · 31 Oct 2026 21:14
- Tyra Biosciences (TYRA) Stock Looks Expensive Against Its Book Value (opens in a new tab) Simply Wall St. · 17 Oct 2026 08:11
- Here's Why Tyra Biosciences (TYRA) is Poised for a Turnaround After Losing 27% in 4 Weeks (opens in a new tab) Zacks · 14 Oct 2026 13:35
- Raymond James Updates Healthcare Top Picks for October (opens in a new tab) Investing.com · 01 Oct 2026 21:26
- Tyra Biosciences (TYRA) Dabogratinib Delivers 57% Complete Response Rate in Phase 2 Trial. Is Phase 3 Supported? (opens in a new tab) Insider Monkey · 16 Sep 2026 21:07
- Tyra Biosciences (TYRA) Stock May Be Priced Too Richly For Its Assets (opens in a new tab) Simply Wall St. · 16 Sep 2026 16:13
- Tyra Plummets To 10-Month Low On Mixed Cancer Test; Why Analysts Are Upbeat (opens in a new tab) Investor's Business Daily · 09 Sep 2026 21:54
- Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress (opens in a new tab) Barrons.com · 09 Sep 2026 15:44
- Tyra Biosciences shares plunge 30% after Phase 2 dabogratinib data (opens in a new tab) InvestorsHub · 09 Sep 2026 15:05
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 19.77 USD
- Market cap
- 1.4B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow TYRA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.